Richard Wardrop

Richard Wardrop, MBA has over 20 years of work experience in the pharmaceutical industry. Richard currently serves as the Senior Director / Head of National Accounts and Distribution at Kiniksa Pharmaceuticals. In this role, they lead a team of 4 Strategic Account Directors and oversees brand and market access activities.

Prior to their current position, Wardrop worked as the Director, Field Access / Payer Strategy Lead at Deciphera Pharmaceuticals, where they developed and implemented the company's payor and distribution strategy. Richard also managed relationships with Specialty Pharmacies and Specialty Distributors.

Wardrop has also held leadership positions at other pharmaceutical companies, including Alder BioPharmaceuticals, Inc., Flexion Therapeutics, and Eisai US. At Alder BioPharmaceuticals, they led the implementation of a payor strategy for a migraine drug and developed an incentive compensation platform. At Flexion Therapeutics, they focused on payor engagement and developed strategies for knee osteoarthritis treatment. At Eisai US, Wardrop managed the US payor strategy for various therapeutic areas and oversaw relationships with health plans and pharmacy benefit managers.

Their earlier career includes sales and management roles at Eisai US, Takeda Pharmaceutical Company Ltd, and ADP. Wardrop has a strong track record of success, receiving awards and recognition throughout their career.

Richard Wardrop, MBA has a Bachelor of Science (BS) degree in Finance from St. John's University. Richard also attended The Wharton School for an unspecified period of time, where they pursued a field of study called Eisai Leadership University. Richard furthered their education at Webster University, where they obtained a Master of Business Administration (MBA) degree with a focus on Business. In addition to their formal education, Richard has obtained certifications in executive leadership and leading without formal authority from LinkedIn.